Medication adherence and tolerability of Alzheimer’s disease medications: study protocol for a randomized controlled trial

BACKGROUND: The class of acetylcholinesterase inhibitors (ChEI), including donepezil, rivastigmine, and galantamine, have similar efficacy profiles in patients with mild to moderate Alzheimer’s disease (AD). However, few studies have evaluated adherence to these agents. We sought to prospectively ca...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Campbell, Noll L, Dexter, Paul, Perkins, Anthony J, Gao, Sujuan, Li, Lang, Skaar, Todd C, Frame, Amie, Hendrie, Hugh C, Callahan, Chris M, Boustani, Malaz A
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2013
Soggetti:
Study Protocol
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3764973/
https://ncbi.nlm.nih.gov/pubmed/23782591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-14-125
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi